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Abstract 
 
Background: Thia study evaluates the effects of Ailanthus excelsa Roxb methanolic extract (AER-ME) in rats induced with Myocardial 
Infarction (MI) followed by transplantation of MSCs.  
Material and Methods: Rats were induced with MI by ligation technique of left coronary artery. The sham-operated the control and 
AER-ME treated group of rats received transplantation of PKH-26 and marked MSCs followed by normal saline and AER-ME treatment 
(200mg/kg/day of AER-ME extract) respectively for 30 days. Parameters such as cardiac function, inflammation, oxidative stress, 
apoptosis and differentiation of MSCs (angiogenesis) were evaluated. Histological studies of infracted myocardium reveled anti-
inflammatory activity of AER-ME treatment. 
Result and Discussion: Oxidative stress parameters revealed decrease in levels of malondialdehyde (MDA) and increase in superoxide 
dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSHpx) activity significantly indicating antioxidant activity of the extract. 
There was a reduction in cell death rate of treated rats due to the decrease in apoptotic index with prolongation of MI when compared to 
both control and sham-operated groups. The expression of Fas protein was parallel to apoptotic index. The vascular density increased 
significantly in extract treated group. The treatment showed improved cardiac activity with decreased left ventricular end diastolic 
(LVEDP) and arterial pressure while the left ventricular end systolic pressure (LVEP) and dp/dtmax increased significantly when 
compared to both control and sham-operated groups respectively showing the protective effect of the extract as necessitated by the 
transplantation of MSCs. The study marked the protective outcomes of AER-ME treatment for MSCs in microenvironment of infracted 
myocardium by improving their viability and increasing differentiation into cardiomyocytes.  
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Introduction 
 
Ischemic heart diseases top the list of the growing cause of deaths in developing countries. Post infraction condition results in 
heart muscles being reduced to diminished capacity for self-renewal; hence restructuring itself with low left-ventricular activity Pfeffer et 
al. (1990). Myocardial infarction (MI) is associated with a loss of valuable cardiomyocytes and eventual gain of fibroblasts which 
contributes a major reason of heart failure. Studies have reported presence of precursor cells in heart, destruction of valuable 
cardiomyocytes in major leads to heart failure Oh et al. (2004). Treatment lines for MI include traditional drug therapies and surgical 
procedures to improve the blood perfusion to infracted cardiac muscles, restoring myocardium would be a choice of treatment. Recently 
treatments involving the use of growth factors for angiogenesis are being adopted VEGF and found to be a key responsible growth factor 
by increasing the differentiation of cells. (Heba et al. 2001; Cohen et al. 1994; Xie et al. 1997).  
Mesenchymal stem cells (MSCs) originate from non-hematopoietic system. These cells are found in all tissues Da Silva et al. 
(2006) namely bone marrow, fat tissue, synovial membrane, muscles, placenta, amniotic fluid and umbilical cord Orbay et al. (2008). 
Chiefly found in bone marrow, MSCs have the ability to differentiate into variety of cells including nerve and vascular endothelial cells 
and reports also suggest their differentiation into skeletal muscles [Jiang et al. 2002]. MSCs have hence demonstrated promising role 
recently in Cell based therapies. Several studies are reported for differentiation of MSCs in-vitro and in-vivo. Reports indicating 
differentiation of MSCs in vitro in dexamethasone enriched media have been concluded Differentiation into osteo-cell lines and hence 
participation in bone formation (Bruder et al. 1997, 1998; Siddappa et al. 2007).  Studies suggesting possibilities of MSCs playing pivotal 
role in regeneration of vascular tissues are said to play a key role in associated therapies such as impotence, disseminated sclerosis and 
conditions associated with spinal cord injury (Albersen et al. 2011; Steffenhagen et al. 2011). Regenerative cell therapies are making use 
of MSCs as cell sources for repairing damaged tissues, heart muscles and bone Chatterjea et al. 2010. Literatures suggested clinical trials 
directed towards the improvement of cardiac functions followed by myocardial infarction (Abdel-Latif et al. 2007; Wollert et al. 2004). 
Although with MSCs playing a key role in cell mediated therapies of MI, the clinical application of MSCs still remain under 
concerns due to their poor viability into the destructed myocardium post-implantation. Studies suggested MSCs died within 1 week after 
transplantation into infracted myocardium environment in human heart Toma et al. 2002. This report concludes the unsuitability of 
infracted myocardium for survival of MSCs and there further differentiation into cardiomyocytes which either could encourage cardiac 
function in the acute phase of infraction (Dong et al. 2006; Piao et al. 2005; Kamihata et al. 2001). Hence for a MI therapy followed by 
MSCs transplantation, the success relies on increasing the survival rate and there further differentiation. 
Ailanthus excelsa Roxb is tall and leafy tree widely distributed in world with prevalence in countries like Japan, China and 
regions of Australia. The bark AER is found to contain sitosterol, Quassinoids and Ailantic acid Kumar et al. (2010). The bark of AER 
finds place in ancient Chinese medicine for treating alignments such as diarrhea and dysentery associated blood in stools Chopra et al. 
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(1958). In Australia the bark is used for its activities such as anthlementic, malaria and asthma Kirtikar (2003). African traditional 
medicines have established role of bark extracts in conditions of high blood pressure Sharma (1996). The methanolic extract of leafs 
found to contain six flavonoids demonstrated ACE inhibitory activity Loizzo et al. (2007).  
As far as the use of traditional drug therapies associated with chronic myocardial infraction are concerned  studies have shown 
synergistic role of Angiotensin Converting Enzyme inhibitors (ACEi) in expression of VEGF in process of angiogenesis in myocardial 
infracted rats treated with MSCs cell lines. Studies have concluded role of angiotensin system in angiogenesis and growth factors. There 
are few reports correlating link between role of ACEi and expression of VEGF in process of angiogenesis Dan-Yang et al. (2004).  
The goal of present study was to evaluate possible working mechanisms for AER-ME on transplanted MSCs in rats subjected to 
infraction. The study would also establish experimental evidences for the use of this flavonoids enriched methanolic extract as a 
supplement during cellular therapy of MI.  
 
Materials and Methods 
Chemicals 
 
For the experiments, reagents and diagnostic kits involved in the study include Fetal bovine serum (FBS), penicillin and 
streptomycin, Low-Dulbecco’s modified Eagle’s medium (L-DMEM), trypsin-EDTA, were procured from Gibco-BRL (USA); oxidative 
stress measuring kits for assay of MDA, SOD, CAT and GSHpx were obtained from Nanjing Jiancheng Bio. Ins. (China). The methanolic 
extract of Ailanthus excels (Roxb) was produced in own lab from leaves of the same using a soxhlet assembly. The Cell Death Detection 
kit (In situ) was procured from Nanjiang Bio. Ins. China; Antibody used in the study Fas was obtained from San Diego, CA, USA 
(Antibody Design Labs) remaining chemicals obtained from Sigma (USA). 
 
Animals  
 
For the study, male Sprague-Dawley rats weighing between 250 ± 20 g were supplied by Shanghai Medical College from the 
Department of Experimental Animal Center (Shanghai, China). Animals were kept in polyethelene cages supplied with adequate food and 
water and maintained as per the guidelines given by institutional ethical committee. 
  
Isolation and Culture of MSCs 
 
The process started with the collection of bone marrows from tibias and femurs of male Sprague-Dawley rats. The MSCs were 
separated by method described by Yan-Li Liu et al [27] in which femurs were injected by a needle to collect the marrow under strict 
aseptic conditions. After collecting the marrow the cells were subjected to repeated washing by L-DMEM. After washing cells underwent 
centrifugation in a cooling centrifuge at 1500 x g for 20 min followed by resuspension in DMEM medium enriched by 10% FBS, 100 
U/ml penicillin, 2 mM/L L-glutamine followed by 100g/L streptomycin. The whole mixture was subjected to seeding into flasks. After 24 
hr the non-adherent free cells were removed by switching the culture medium after 48 and 72 hr.  
After MSCs had grown to 80% obtained cells were plated again in two separate new flasks. Preparation of subculture was done 
by re-suspending the cells in mixture of 0.25% trypsin + 0.02% EDTA and tagged with 4’6-diamino-2’-phenylindole (DAPI, Roche 
Diagnostics) before implanting them in the experiment. 
 
Model for Myocardial Infarction and Transplantation of MSCs 
 
The MI model was created by ligation technique of left coronary artery in Sprague-Dawley rats according to the process 
described by Pouzet et al. (2000).  Pentobarbital sodium (45 mg/kg Intraperitoneally (IP)) was used to anesthetize rats which were 
ventilated tracheally by normal environmental air using a ventilator (CIV 101, Colombus Instruments, Colombus, OH). The heart was 
operated for left thoracotomy, the procedure for Ligation of coronary artery was carried out 1-2 mm directed away from the line between 
the left and the right border of the pulmonary conus and left atrial appendage respectively. Echocardiography (ADI Instruments, Houston, 
USA) was done to confirm MI by monitoring the ejection fraction of the ligation operated rats. The Ligated rats were transplanted with 
200 μl of suspension bearing a total sum-up of 1x105 MSCs which were tagged with a cell tracker dye PKH-26 red fluorescent cell (Red 
Fluorescent Cell Linker Kit; Sigma) injected in four different sites surrounding infracted myocardium using a tuberculin injection. The 
animals underwent surgery for closure of chest cavity followed by transplantation of MSCs. Grafted rats underwent recovery in a 
chamber under controlled temperature conditions until were found reasonably alert and mobile. Animals were then shifted to cages. 
Rats were divided into three groups as sham-operated, control and AER-ME treated groups (n=18). The sham-operated group 
rats were subjected to MI infraction by ligation but were not transplanted with MSCs cell cultures. The control group received MSCs 
transplantation followed by 3 ml normal saline solution (0.9% Sodium chloride IP) and AER-ME treated post MSCs transplanted group 
received 200 mg/kg/day of methanolic extract IP. The treatment regimens were split into two IP injections/day. After 1, 7 and 30 days of 
MSCs transplantation and respective treatments hearts of six rats from each group were surgically removed and fixed using 4% neutral 
formaldehyde for further studies. 
 
Assessment of Cardiac Activity  
 
After MSCs transplantation cardiac function was measured as per the protocol described by Yan-Li Liu et al (2014). After 30 
days sham-operated, control and AER-ME treated group rats (6 from each group); cardiac activity of animals was monitored using a 
physiological recorder (J. Tongyong Indu. Co., Ltd., China). Rats were anesthetized using Ketamine 100mg/kg and Xulazine 1.5 mg/kg 
after recording the weights of each subject carefully followed by application of transducer (Jinjiang T. Ind. Ltd. China) on the thorax 
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region (Left). The visualization of heart (left ventricle) was done by viewing axially opting a 2-dimensional mode. 
A cannula was inserted inside the left ventricle. Parameters such as LVEDP, LVESP, left ventricular ± dp/dt (maximum rate of 
pressure rise) and arterial pressure were calculated using EC Toolbox software (Emory University, USA). 
 
Histopathological Examination 
 
All the animals treated for 1 and 30 days of treatments of normal saline and AER-ME were sacrificed by a high amount of 
anesthesia. The sacrificed rats were operated and cardiac tissues of the left ventricle were recovered and subjected to fixation process in 
4% p-formaldehyde (for in situ perfusion fixation) by inserting a needle in the left ventricle via left atrium. The recovered tissues of 
myocardium were fixed in wax paraffin and were sliced into sections of 5 μm for histological studies. Staining of sections was done by 
hematoxylin and eosin dies (H&E) as per the instructions given by the manufacturers (Beyotime Bio. Inst.China). Stained sections were 
subjected to microscopic analysis at 100x and 400x. 
 
Determination of Oxidative Stress Markers 
 
For the study the rat models for MI divided into three group treatments were used. Sham-operated, control and AER-ME group 
rats were sacrificed after 1, 7 and 30 days of treatments using high dose anesthesia. Animals were operated along the greater curvature for 
removal of heart and washed with phosphate buffer saline (PBS). The heart was homoginated using a tissue homogenizer and then the 
homogenates were subjected to centrifugation (10,000 rpm for 15 min), the supernatant of heart tissue homogenates were subjected to 
oxidative stress assay for antioxidant enzymes using kits for measuring activity of GSH-Px, CAT and SOD. Marker for lipid per oxidation 
MDA content assays were done using kits, all the protocols were done according to the procedure given by the manufacturer. 
 
In Situ Cell Death Detection and Histochemical Analysis 
 
The tissue sections from animals were subjected to Terminal dUTP nick-end labeling (TUNEL) assay using cell death detection 
kit (Nanjing KeyGen Biochemical Institute, Nanjing, China). The procedure followed was as per the manufacturer instructions. The 
stained tissue sections were observed by conofocal microscope (Leica, Germany). AI was computed by dividing count of 
TUNEL-positive cells with that of transplanted PKH-26 pre-labeled cells.  
Vascular density studies were carried in 6 animals from each group; animals were sacrificed on day 30 after transplantation of 
MSCs followed by respective treatments. The sections were subjected to hematoxylin and eosin staining. Counting of capillary vessels 
was done in zone of tissues subjected to infraction. Angiogenic effect followed by MSCs transplantation was assessed by making 
capillary vessels count within the infracted zone under light microscopy at 400 × magnification for five different regions in the infracted 
area in both the groups and results were represented as the average of capillary vessels/0.2 mm2area. 
 
Study for Expression of VEGF Protein  
 
Western blot analysis was done using polyclonal antibodies of rabbit against VEGF (Zymed lab.Co.).  The myocardial tissues 
of rats were homogenized in mixture of 0.1 % Tween-20 buffer and protease inhibitor. Protein of volume 50 μg was transferred to tissue 
containing buffer and was bundled on a 7.5 % sodium dodecyl sulfate-polyacrylamide gel followed by blotting using a polyvinylidene 
fluoride membrane. After 2 hr waiting time the membrane was transferred with primary antibody (1:200) and incubated.  The membrane 
was then incubated with horseradish peroxidase labeled with a secondary antibody diluted at a ratio of 1:1000.  Densitometric analysis 
revealed formation of positive protein bands obtained on exposure to di-aminobenzidine. Quantitative analysis of myocardial tissue for 
VEGF was calculated by performing enzyme immunoassay. The VEGF levels were quantified similarly 7 days after the culture of 
transplanted MSCs Xu et al. (2005). 
 
Statistical Treatments 
 
All results are described as average SEM and were calculated using statistical software (GraphPad Prism 5). P values were 
calculated using the data. 
 
 
Results 
Characterization of Mscs for Presence of Surface Markers 
 
The cultured MSCs were found positive for mesenchymal markers including CD44, CD105, and CD90 and did not express 
surface markers for hemotopoietic stem cells i.e. CD45, macrophages CD14 and markers for lymphocytes CD34. 
 
 
Assessment of Cardiac Function Followed by AER-ME Treatment  
 
The sham-operated, control and AER-ME group rats (n=6) were assessed for variety of parameters of echocardiography 
followed by analysis of hemodynamics.  Both the AER-ME and control groups demonstrated decreased left ventricular end diastolic 
pressure (LVEDP) and Arterial pressure (systolic and diastolic) while the LVESP and dp/dtmax increased showing protective effect of 
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MSCs treatments. Results when compared to control group the AER-ME group showed significant improvement in cardiac function 
parameters proving ameliorating effect in MI rats. The results are presented in Table 1. 
 
 
Effect on MI-Induced Heart Inflammation 
 
Histopathology of myocardial tissues subjected to H&E staining, the images showed MI induced changes in the myocardium 
makeable by the presence of mononuclear cells, eosinophils, macro phagocytes, polymorph nuclear neutrophils and fragments of necrotic 
myocardial fibers. When compared to group supplemented with AER-ME followed by MSCs transplantation after 30 days, reduction in 
number of inflammatory cells was observed in the stained sections (Fig. 1). 
 
 
Table 1: Results of cardiac function, data are produced as the mean ± SEM for n=6. aP<0.005 compared to sham-operated day 1, 
bP<0.005 compared to day 1 rats, a,bP<0.05 compared to sham-operated and control groups. 
 
Groups 
Day-1 Day-30 
Sham- 
operated 
Control AER-ME 
 Treated 
Sham- 
Operated 
Control AER-ME  
Treated 
LVEDP 
(mmHG) 
11.2±0.46 9.1±0.33a 9.3±0.40a 12.9±0.68b 8.3±0.45a,b 7.9±0.23a,b 
LVESP 
(mmHG) 
101.3±2.93  88.9±2.33 a 90.1±2.98a 92.3±2.2b 102±2.44 a,b 110±3.16 a,b 
dp/dtmax 
(mmHg/sec) 
5960±75.3 6167±93.4 a 6250±69.52a 5530±57.8b 6650±81.5a,b 8430±57.74 a,b 
Arterial  
pressure 
(systolic) 
(mmHG) 
126±5.77  102±3.01 a 107±2.92a 155±6.45b 110±2.89a,b 116±2.78 a,b 
Arterial  
pressure 
(diastolic) 
(mmHG) 
102±2.89  88±3.15 a 95±2.7a 112±2.92b 93±3.01 a,b 89±3.01 a,b 
 
 
 
 
Figure 1: Anti-inflammatory effect using H&E staining images of cardiac muscles (A) The sham operated group showing necrosis of 
myocardial tissues, signs of infiltration of neutrophils. (B) Control group rats showing healing of necrosis of myocardial tissues (C) AER-
ME treated group shows decreased tissue necrosis and infiltration of neutrophils. 
 
Anti-Oxidant Effects of AER-ME on the Heart Tissue Homogenates 
 
For the study AER-ME, control and sham-operated group rats were sacrificed (day 1,7 and 30) and cardiac tissue homogenates 
were evaluated for levels of SOD, CAT and GSH-Px and MDA. Results demonstrated significant antioxidant potential of MSCs 
treatments in both the treated groups showing an increase in activity levels of SOD, CAT and GSH-Px and decrease in levels of 
Malondialdehyde a lipid per-oxidation product as compared to sham-operated rats. The results demonstrated a synergistic effect of AER-
ME treatment on oxidative stress markers, the results were significant (p<0.05) and are presented in Figure 2.  
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Figure 2: Results of AER-ME treatment followed by MI caused oxidative stress. Levels of SOD, CAT, GSH-Px and MDA. *P<0.001 
compared to sham-operated group day 1, €P<0.001 compared to control day 1, #P<0.001 compared to sham-operated day 7, $P<0.001 
compared to sham-operated day 30. 
 
Figure 3:  Images by conofocal microscope showing PKH-26 labeled cells (Red) and TUNEL assay cells (green) in control and ASE-ME 
extract treated groups on day-1 and day-30 of treatment. 
 
Effect of AER-ME Extract on MI-Induced Mscs Apoptosis 
 
The MI induced rats were transplanted with PKH-26 labeled MSCs cells into the infracted region. The apoptosis of cells was 
identified by TUNEL assay staining positive with green. The images by conofocal microscope showing PKH-26 (red color) and TUNEL 
(green color) which suggested programmed cell death post implantation of MSCs cells (figure 3). Results demonstrated apoptotic index 
(AI) significantly decreased in AER-ME treated rats (P<0.001) against control and sham-operated group of rats. After transplantation of 
MSCs the AI index increased in all the three groups when analysed on day-1 and day-30. The results are presented in figure 4. 
 
Evaluation of Angiogenic Effect (Vascular Density Studies)   
 
Vascular density studies were done to mark the angiogenic effects. Microscopic evaluation was done by light microscope 
(magnification, 400 ×) for sections stained with hematoxylin and eosin. Counting of capillaries in infracted zones revealed differentiation 
of MSCs into new capillaries in the ASE-ME and control groups which were subjected to infraction followed by MSCs transplantation, 
while the sham-operated group showed no evidence of angiogenesis and also showed a higher death rate. The group of rats supplemented 
with AER-ME treatment (for 30 days) presented results having vascular density significantly higher (P<0.001) versus the control group 
rats, suggesting a synergistic role of the AER-ME supplementation. Examination of peri-infracted area do not exhibited a variation in 
vascular density in both the groups. The results of vascular density are shown in figure 5.  
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Figure 4:  Results of AER-ME treatment on AI in sham-operated, control and AER-ME treated groups. *P<0.005 against respective 
sham-operated group, $P<0.005 against respective control, #P<0.005 against respective sham-operated group, @P<0.005 against respective 
control. 
 
Analysis of VEGF (Western Blot Analysis)  
 
Results of Western blot analysis (figure 6) showed increase in the VEGF protein levels 7 days after MSCs transplantation in 
both the control and AER-ME treated groups. It was found that levels of VEGF decreased in sham-operated rats. The enzyme 
immunoassay (ELISA) suggested levels of VEGF increased significantly in AER-ME treated rats as compared to control group rats. 
Results are presented in figure 6.  
 
 
 
 
Figure 5: Results of Vascular density analysis in sham-operated group, control group and AER-ME treated group of rats. *P<0.001 
against sham-operated, #P<0.001 against control. 
 
 
Figure 6: (A) Results of Western blot for expression of Fas protein (B) Quantitative study of myocardial tissue contents of VEGF. AER-
ME treated group *P<0.001compared to sham-operated and @P<0.001 against control 
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Discussion 
 
Therapy involved with grafting of MSCs have found to improve heart functions in infracted animal models, the property is 
contributed by differentiation of MSC into myocardial cells. Differentiation is however required further for improved cardiac functions 
specifically in infracted zones of myocardia. The present research examined role of methanolic extract of Ailanthus excelsa Roxb (AER-
ME) which was reported to have flavanoids. The study indicated MSCs transplantation in myocardial infracted rats followed by treatment 
of AER-ME ameliorates the cardiac functions in MI induced rats. This also confirms partial protective effect of AER-ME for the 
transplanted MSCs against the MI caused apoptosis and also the treatment of extract promotes the differentiation of grafted MSCs into 
cells of myocardia.  
Literatures confirm presence of six flavonoids in methanolic extracts exhibiting ACE inhibitory and anti-inflammatory activity, 
the extract is documented to treat asthma and ulcers also Kumar et al. (2010). Literatures also support role of ACE inhibitors in 
expression of VEGF proteins in process of angiogenesis in myocardial infracted rats grafted with MSC Izuagie et al. 2015. Present study 
confirmed that AER-ME increases the expression of VEGF proteins and thereby enhancing survival and differentiation of transplanted 
MSCs into myocardial cells in infracted rats. The study concluded that supplementation improved cardiac functions as compared to 
untreated group of rats.   
Induction of MI in rat models is often associated with cardiac inflammation; studies have confirmed that inflammation remains 
one of the main causes for death of grafted MSC in treatments associated with MI.  Present study confirmed treatment of AER-ME 
significantly brought down the infiltration of inflammatory cells into the infracted zone of myocardium confirming its established anti-
inflammatory activity. 
The treatment of extract confirmed the antioxidant property which was consistent with other studies performed in vivo and in 
vitro Kumar et al. (2010). The extract treated groups established significant antioxidant effects by showing enhanced activity levels of 
enzyme SOD, CAT and GSHpx and reduced levels for MDA. Study responded well with time and showed significant results after 30 
days of treatments. 
The study further confirmed protective effects of AER-ME against infract induced apoptosis of MSCs in the process of 
implantation in rats. The TUNEL-positive rate of the MSCs decreased significantly in rats subjected to AER-ME treatments and was 
inversely proportional with treatment time of AER-ME in rats.  
The Fas protein expression studies were carried to determine the possible pathway of cell apoptosis. The studies concluded that 
treatment of AER-ME significantly down regulated the manifestation of Fas protein and was found to be inversely proportional to 
treatment regime of the AER-ME. Hence the studies partially confirm role of Fas signaling pathway as possible mechanism behind cell 
apoptosis, however further studies are required for a clear mechanism.    
Evaluation of cardiac functions in infracted rats treated with AER-ME extract reveled improved cardiac functions. The vascular 
density increased significantly in both control and AER-ME treated rats grafted with MSC as compared to sham-operated rats, however 
the extent of angiogenesis was significantly high in AER-ME treated rats confirming a synergistic role of extract in angiogenesis.   
The results of present work revealed protective role of AER-ME on MI which was followed by transplantation of MSCs. The study 
also established protective role of AER-ME extract for transplanted MSCs against the MI caused apoptosis. The study also confirmed Fas 
arbitrated pathway for cell apoptosis. Study established role of AER-ME against inflammation in infracted zones of myocardium. The 
results suggested that treatment reduced oxidative stress and also increased expression of VEGF protein and hence increased vascular 
density.  The study proves promising role of AER-ME extract in MSC grafted MI therapy. However presence of six flavonoids in 
methanolic extract of Ailanthus excelsa Roxb increases need of further investigation with detailed mechanisms of specific flavonoids 
involved. 
The present study concludes and evidences that AER-ME is able to ameliorate the cardiac function in myocardial infracted rats 
transplanted with MSCs. Study also established that treatment of AER-ME increased the endurance and differentiation of transplanted 
MSCs; the treatment also attenuated inflammation in tissues and reduced oxidative stress in the myocardial tissues of MI induced rats. 
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